1. Background.
The motivation.
The primary function of the irnrnune system is to protect the body from foreign, potentially pathogenic, invaders. The symptorns of the earliest stage of a normal immune response, inflammation, are redness, swelling, pain and increased local temperature. The initiation of inflammation by skin infections or damage to the skin triggers resident skin cells to release molecules that cause blood vessels near the skin surface to become permeable. This increase in blood vessel permeability allcHvfi irnrnune cells and factors circulating in the blood to rapidly enter the infected or damaged area and, as a consequence, initiate the development of immunity. When infection or damage occurs for the first time, precursors of cells that initiate irnrnunity are recruited out of the blood follm'ling a gradient of molecules called inflammatory chemokines that are induced at the site. In order to follow chemokine gradients produced during inflammation, these cells require receptors on their surface for specific types of inflammatory chemokines. The material, generally derived from microbes, that the irnrnune cells react to at the site of inflammation is known as antigen. A subpopulation of immigrant cells rapidly develops into dendritic cells (DCs) in the skin that sample and process the antigen for presentation to T cells ''lithin local lymph nodes. Coincident ''lith antigen uptalce, DCs are activated by a '"danger sigl1aF' that induces maturation of the cell resulting in receptor type changes displayed on the cell's surface (Figllre 1). 1-licrobial DNA, RNA from viruses, bacterial peptidoglycan aJld lipopolysaccharide (LPS) caJl all act as danger signals. Cytokines, soluble intercellular messenger molecules produced during inflammation, e.g., tumor necrosis factor alpha (TNF-Q), also act a."i intrinsic danger signals for DCs, for example in the chronic disease model such as psoria."iis [1, 101 . The ne,'l receptors resulting from the danger signal, referred to as CCR 7 receptors, enable DCs to follm'l a gradient of another set of chernokines, the constitutive chemokines, termed CCL19 and CCL21, ''lhich guide the cells from the skin via lymphatic ducts to the lymph node. \~.Tithin specialized areas of the lymph node, antigen is presented by DCs to T lymphocytes. These T lymphocytes are constaJltly circulating from the blood system through the lymph nodes. Those T cells that recognize antigen presented by DCs become activated and proliferate ''lithin the lymph nodes. Eventually, the T cells leave and travel to the skin to assist in the removal of the antigen by secreting molecules that drive inflammation. A gradient of chemokines is again required for this movement. During a normal response, inflammation ceases once the antigen is removed or healing are constantly being recruited to the skin from the blood (1) saJnpling antigen in the skin and migrating to the lymph node (2) ,vhere they induce the activation and proliferation of T cells (3) that travel bade to the skin ,vhere they release cytokines thus maintaining the inflammatory condition. is complete. Smne components of this irnrnnne cell movement are not restricted to the inflammatory response. In non-inflamed healthy skin, minor traffic of DCs from the skin to the lymph nodes consistently occurs. The purpose of this "steady staten migration is to a.%ist the irnrnune system in remaining toleraJlt tmva.rds body components, i.e., "selC' On occasion, the immune system induces prolonged skin inflammation. This chronic inflammation is due to an aberrant immune response to either foreign material or to normal body components that does not resolve. In this situation, cells continue to produce cytokines and chemokines and to move in and out of the skin which prolongs inflammation. One way to intervene in this process is to block the movernent of irnrnune cells. 1.folecules derived from viruses, termed chernokine binding proteins, have been identified that have the capacity to do this and therefore may have potential as anti-inflammatory therapeutics. We are interested in developing a mathematical model of this. Preliminary to this, ,ve need to model (1) the recruitment of blood derived DCs in response to inflammatory stimuli and antigen in the skin, (2) the trafficking of antigen-loaded skin DCs to the node, and (3) subsequent T cell activation aJld proliferation under normal conditions. The mathematical model described in this paper represents these events. 2. The model. An ordinary differential equation (ODE) model was developed that enabled us to measure the levels of DCs in the lymph node, DL (DCs/mg of lymph node), and in the skin, Ds (DCs/mg of skin), over time t (in hours). In addition, the aJltigen concentration, A. (ng of antigen/mg of tissue) and the number of effector T cells (both CD / l aJld CD8), denoted T (''lith units of cells/mg of nodal tissue) \vere tracked. All model parameters and initial values are given in Table 1 .
Regarding ''lhat "antigen ll represents in the context of our model, ''le note that antigen that provokes DC movement in the first instance may be microbial, in which case it will replicate, and at a specific threshold (generally poorly defined), sufficiently activated DC will exit the skin. Alternatively, antigen may be a finite amount of protein which by definition will not increase. An example may be a contact allergen applied to the skin. And yet again, microbial antigen may mimic "self aJltigen ll so that in aJl autoirnrnune disease, the irnrnune response, initiated by antigen from the environment, may be perpetuated by a constaJlt supply of "seIF antigen, for exmnple, cell components. Since our model is limited to incorporating the initiation of DC activation and movement to the draining lymph node in response to a given antigen, we have chosen to use a defined, finite quantity of proteinaceous antigen in this preliminary model. Since different microbes replicate at different rates under different conditions, it would be difficult to do otherwise.
We note that in a case of chronic inflammation, the model would be far more complicated, and more than one lymph node ''lould be involved. IIm'lever, in this preliminary model of DC trafficking, we focused on modeling the dynamics within only one lymph node. This model describes mathematically the induction of T cell immunity in the skin, as a first step toward developing a model of chronic inflammation. We incorporated only the simple elements of DC antigen acquisition, activation, movement, and T cell stimulation. Future, more complex, models can build on this preliminary model in directions that can potentially allm'l not only for model validation, but also for predictions aJld hypothesis testing.
2.1. Assumptions and ODEs. The mathematical model uses the follm'ling assurnptions:
1. The concentration of DCs in the blood, DB, remains relatively constant throughout the simulation. This implies that an ODE representing DCs in the bl~)()(l \vould have the form d~tD ;::::; 0 for the duration of the infe(:tion and subsequent inflammation, and thus an equation for DB is not included. 2. Antigen accumulates in the skin linearly over time until it reaches a maximurn level There is no evidence that this is not the c~J.."ie, and it allcnvfi for a tractable mathernatical implementation. 3. In the absence of sufficient antigen, the number of DCs that migrate to the lymph nodes is very smalL Sufficiently high levels of antigen stimulate increased DC flow from the blood to the skin and thus from the skin to the lymph node. 11. Dendritic cells do not proliferate in the skin. This assumption is based on data derived from the inflammatory response when immigrant monocytes enter the skin, differentiate, acquire antigen in the presence of co-stimulatory danger SiglUllS and migrate to the draining nodes. Langerhans Cells, the normal residents, are knm'ln to turn over (that is, replicate) extremely slm'lly in the skin [6, 11] . Dendritic cells that are known to participate in an inflammatory response are recruited primarily as monocytes from the blood and are not knm'ln to proliferate in the skin. 5. \~.Te knm'l that behveen Cl.Ol % and 3% of mature antigen-loaded Des that leave the skin get to the node [8] . This suggests that there are probably quite large losses along the ''lay possibly during migration. In the model, ''le are only interested in tracking those Des that pick up antigen in the skin and are capable of activating T cells once they reach the lymph node. Therefore, ''le ''lill assume that Des that reach the node are all capable of activating T cells. 6. T cells do not begin to proliferate until the concentration of Des in the lymph node reaches a certain threshold. This critical threshold is represented in the model by parameter DL"rir'
The cycle of De activation begins ''lith aJltigen stimulation. A fe,'l hours after initial antigen stimulation, antigen is assumed to reach a sufficiently high level to elicit an inflammatory response. In particular, we represent the process of infection initiation by allm'ling antigen concentration, A, to increase linearly ''lith time from the start of the simulation until A reaches a maximum threshold, Athrei-ih (see Assurnption (2)). The time at ''lhich this threshold is reached is tthrei-ih' For simplicity, \ve assume that antigen levels A increase by one ng per mg of tissue per hour, until reaching threshold Athrei-ih. Defore that threshold is reached, a lm'l level of Des continuously flows from the blood into the skin. This constant inflow is represented by aDD (see equation (2) belm'l). Once aJltigen levels in the skin hit the critical threshold, Athrei-ih, Des are recruited from the blood into the skin at a higher rate. In the model, this is represented by having the value of aDD increase (see discussion in section 2.3). \~.Te make the assumption that the increase in the recruitment rate takes place on a short enough time scale that the increase in aDD can be approximated by a discrete jump from a non-inflamed value to an inflamed value, and that the use of a continuous function to represent this grm'lth is not currently required. A continuously increasing recruitment parmneter can be incorporated in a future model.
Dendritic cells in the skin, D s , continuously flow out and travel to the lymph node. The rate of transfer from the skin to the lymph node is described by a rate
As the nurnber of Des in the skin increases, the rate at \vhich Des migrate from the skin into the lymph node is moderated by the function IC The form of I( is outlined in detail in section 2.2.
As noted in Assumption (/1), there is no De proliferation in the skin. This, along \vith the aforementioned antigen activation cycle, suggests that the rate of chaJlge of the Des in the skin caJl be described by the equation
The Des that arrive in the lymph node are assumed to corne solely from the population of Des in the skin. In this model, Des leave the skin at a rate described by the rate function I( and arrive in the lymph node at that same rate. The Des in the lymph node diminish only through death at a rate b (per hour). IIence, the differential equation describing the rate of change of the DC population in the lymph node is dDL
Finally, the T cell population is assumed to grm'l logistically ''lith grm'lth rate 
\vhere a is a function of D L and time and is defined as
\~.Te chose a to have this time-dependent form for the follmving re·a."ions. The T-cell population should not be stimulated to grmv at all until the critical De threshold is reached. At that time, the intention is not simply to discretely s,vitch on the T-cell stimulation by Des, but to allmv T-cell stimulation by Des to increa."ie linearly \vith time until stimulation levels are at a maximurn. This is achieved through the time-dependent form of a. \~.Te set fa = 72 hours, ,vhich is an arbitrary choice that allmvs the a function three days to achieve its maximum value.
In sUlnrnary, the model equations are given by: [7] , the rate at which Des enter uninflamed skin is 2 Des per mg of skin per hour (see discussion of aDD in section 2.3). By the same experiment, the rate of Des entering 1 mg of inflamed skin per hour is 100. Therefore, we will allow The rate function I( uses the nurnber of Des in the skin as a proxy for the physiological roles of tumor necrosis factor (TNF), the chemokine gradient and other biological elements that influence DC migration.
2.3. Parameters and initial conditions. To allm'l for a nurnerical examination of the model system, ''le had to choose parameter values. In this section, \ve describe hm'l ''le arrived at particular parameter values and initial conditions.
• Ds (0) = 0: Ds (0) is the nurnber of Des in the skin at time zero, and is zero initially, since ''le don't expect there be any activated Des in the skin prior to the introduction of antigen.
• DL (0) = 0 : DL (0) is the nurnber of Des in the lymph node at time zero, and is zero initially, since ''le don't expect there be any activated Des in the lymph node prior to the introduction of antigen.
• T(O) = 1: There can be on the order of 10 fl T cells per lymph node, but before antigen stimulation, there should be no primed T cells. For the purposes of streamlining the mathematical model, ''le chose to represent T cell dynamics by a logistic grm'lth term, ''lhich requires mathematically a non-zero initial condition in order to allm'l for any population grm'lth. Therefore, ''le allm'led for a negligible nurnber of sensitized T cells per mg of lymph tissue ''lhen ''le initiated the simulation (one per mg of lymph tissue).
• "fII. = 10: \~.Te estimate that there are approximately 10 T cells per De in the lymph node, and therefore, the carrying capacity of T is "fIlD Lmax 1:3].
• fthrei-ih = 11: The time at ''lhich antigen levels A reach Athrei-ih' See further explanation belm'l for Athrei-ih.
• Athrei-ih = 11: In our model, ''le allm'l antigen levels to incre~J.."ie at a rate of 1 ng/mg of tissue per hour. This is a guess, and ''lill vary depending on the organism. For this reason, ''le allm'l Athrei-ih = fthrei-ih times 1 ng per mg of tissue per hour. In our case, ''le estimated Athrei-ih to be 11 ng/mg of tissue, the point at ''lhich Des start getting recruited from the blood to the skin, after ''lhich the Des talce up the antigen, and migrate to the lymph node. The process of T cell activation by Des in the lymph node is initiated once the concentration of Des in the lymph node reaches DLcrir cells/mg of lymph node. Since there is evidence that De activation takes place about 2 to 11 hours after initial antigen stimulation [5] , ''le set fthrei-ih at 11 IB].
We note that inflammation is initiated by a danger signal, and this danger sigl1al comes from the same mic[(}-organism ~J.."i the antigen, as discussed in the introduction of this paper. Such danger signals are not explicitly accounted for in our model, but instead ''le allm'l the threshold antigen level to dictate the initiation of the inflammation response. We assume that there is sufficient accompanying danger signal to initiate the inflammatory response, allowing De recruitment from the blood to the skin.
• DLcrir = 3 X l(P: According to [3, 9] 3000 antigen-presenting cells per lymph node, or 300 cells/mg lymph node (assuming a 10 mg lymph node), is adequate for T cell response. In our model, we record the first time DLcrir is reached as f erit . Thereafter, the T-cell growth coefficient a(DL' f) grm'ls linearly ''lith time until its value reaches the maximurn, alllCl.X'
• DLmax = 2 X 10 4 : The lymph node in a mouse can hold about 2 x 10 This is the rate of the DCs entering 1 mg of skin from the blood per hour. Rate values for aDD are pre and post-threshold levels of antigen. The lmver bound for the pre-threshold levels m"e based on the experiments of [7] , and the upper bound pre-threshold value is chosen to be a percent of the upper bound post-threshold rate of DC entering inflamed skin. When aDD represents the rate of blood-derived DCs that are recruited to uninflamed skin per hour, the lmver bound value is aDD = 2± (1 SD) / mg of skin per hour. This value of aDD ,vas obtained from experiments in ,vhich DC recruitment from the blood was performed using egfp DC (DC expressing green fluorescent protein) adoptively transferred into syngeneic recipients. Done maumv DCs ,vere cultured from C57DI/6 mice as previously described [2] . 3 x 1()'i egfp DCs ,vere administered into sex matched C57DI/6 recipients via the tail vein 1:1]. Forty hours later mice were sacrificed and an area of skin from the abdomen ,vas excised, 'veighed and the irnrnune cells isolated by enzymatic digestion. The egfp DCs ,vere enumerated by staining the cells ''lith a monoclonal antibody to the cell surface glycoprotein CD11C. The data ,vere obtained using 3 mice per experimental group and 2 experiments ,vere performed. 89 DC ±5 / 1
(1 SD)/mg of tissue were found to be recruited to un inflamed skin over a 48 hour period. The experiment described here and experiments described belmv for determining aD D in the inflamed state were approved by the Animal Ethics Committee, University of Otago. The upper bound value for the un inflamed rate aDD is chosen to be 2% of the upper bound value of the inflamed aDD' since the lower bound uninflamed value is 2% of the lower bound inflamed value. Since the upper bound on the inflamed value is 6250 (see discussion below), we have the upper bound on the uninflamed set at 125"
The range of values for the inflamed state were determined as follows: they are based pmtially on the experiments carried out in [71, and partially on the data provided in [8] . In the experiments of [7] , 1()'i ,vhite blood cells ,vere inj ected into the blood (through the tail vein) of three DLD /6 mice in hvo experiments (for a total of six mice). The injected cells ,vere mm"ked ''lith CD11c for the tracking of the nurnber of DCs. After 2/1 hours, a mean of 2 / 100 (±9 / 1) DCs per mg of skin ,vere hanrested from the mice. So in this experiment, about 100 DCs per mg of skin appear to enter the skin per hour. \~.Te ,vill allmv this to determine the lmver end value of aDD' setting it to 100. According to [31, about 300 DC/mg of lymph node are needed to initiate aT cell response. The experiments of [7] are consistent ''lith this.
In order to get an upper bound on aDD' ,ve look at [8], in ,vhich ,ve see that in smne c~J.."ies, as fe,v as about 0.1% of activated DCs in the skin manage to migrate to the lymph node. If ,ve ,vork badnvards from the threshold of 300 DCs/mg of lymph node needed to activated a T cell response, assume that it takes about 2 days, or 118 hours, for the activated DCs to build up to that level in the lymph node, and then suppose that only 0.1 % of activated DCs actually make it to the lymph node (according to [81) , ,ve have the follmving outcome: 300 DC/mg of lymph node built up over 118 hours means an average of 6.25 DCs/mg of lymph node are entering the lymph node per hour. If this represents only 0.1 % of the activated DCs that make it from the skin to the • is = 1/72: Dendritic cells die in the lymph node after approximately 3 days, so the rate of DL dying in the lymph node per hour, is, is 1/72. The estimates of a three day life span are given in [6].
• alllCl.X = 0.1, 0 ~ a(DL,f) ~ alllc\'x: This is the grmvth rate ofT cells in 1 mg of lymph node per hour. \~.Te chose alllc\.X = 0.1, ,vhich is a guess, and a value that allmvs the T cell population to increase at a biologically reasonable rate. Table 1 . aDD = 100. Table 1 . aDD = 500. Rate of DC migration from Skin to Lymph Node, alphBob = 1000 • T cells reach a maximurn equilibrium value.
• Once DL reaches its maximurn value, Ds begins to grmv since Des in the skin migrate at a lmver rate from the skin to the lymph node.
• DL achieves its steady state value roughly at the same time T cells do. This is appropriate since DLs stimulate T cell production.
In the inflamed state, when aDD increases to 500 and higher, ,ve notice that the T cell response takes place more quickly (see Figures 2 through 5 ). As expected, the concentrations of Des in the skin and in the lymph node increase more rapidly in the initial hours. For aDD at 100, steady state values are achieved for Des in the skin and lymph node, and are about equal. For the larger values of aDD' the Des in the skin appear still to be increasing, even at time 250, but the Des in the lymph node have achieved their steady state value of around 10 4 Des per mg of lymph node (the rnaximurn that can be held in the lymph node tissue). The next steps in developing this model ,vill include:
• Cell loss 'in tTan,4rit'ion. Currently, ,ve assume that DCs leave the skin and arrive in the lymph node at a rate IC It may be useful to explore the effect of concurrent cell loss. In the model, this is easy to implement. \~.Te can introduce a parmneter p, ,vhere 0 ~ p ~ 1, and simply modify the equation for the DCs in the lymph node to read a."i follmvs: d~/ = pK(Ds,DL)Ds -bDL.
• The Tate jlLnd'ion Ie I ((D s , D L ) is a simplified function in which the physiological roles of tumor necrosis factor (TNF) and the chernokine gradient are not included explicitly, but their roles in DC migration are only approximated by the nurnber of DCs in the skin. Future models ,vill incorporate secondary chemokines such as CCL19 and CCL21 as well as the TNF's effect on inflammation and secondary chemokine production. In addition, we hope to find better values for parameters, potentially through designing experiments in collaboration behveen the mathernaticians and the biologists. Since movement of DCs from the skin to the lymph node is not an instantaneous process biologically, ,ve plan to investigate the introduction of a time delay behveen DC loss from skin and arri val at the lymph node. \~.Te note here that ,ve model the lymph node, and not the lymph, because ,ve caJl obtain data from the literature aJld from our mvn experiments. Deriving data from lymph is not easy in the mouse. It can be done in larger experimental aJlimals by cannulating lymphatic vessels, for example in the rat [12] .
• Capturing chronic infiammation. In this preliminary model, ,ve have not yet included T-cell clearing of antigen, and the persistence of the T-cell population once it is activated is essentially imposed. In a future model that ,vill build on this model, and in ,vhich ,ve intend to capture the mechanisms that lead to chronic inflammation, the dynamics will have to be modified to allow the inflamed state to emerge from a set of rules that do not explicitly impose such a state.
• The 'value of aDD' aDD is the rate at ,vhich DCs are recruited into skin, ,vhich depends on the antigen concentration. \~.Then the antigen concentration has not yet reached a threshold, Athrei-ih, we consider that inflammation has not been triggered. \~.Te are currently investigating an implernentation of a more biologically accurate definition of aDD'
